Lipoprotein patterns in diet, sulphonylurea, and insulin treated diabetics.
In order to study the lipoprotein pattern in diabetes mellitus, plasma lipoproteins were isolated by rate zonal centrifugation in 12 control subjects (median fasting blood glucose level: 80 mg/dl (range: 74-86)), 14 diabetic patients treated by diet alone 104 mg/dl (76-153), 27 patients treated by diet plus insulin (180 mg/dl (106-404)), and 32 patients treated by diet plus sulphonylurea [178 mg/dl (103-361)]. No significant differences of median relative body weight existed between the four groups. Neither the diabetic group on diet alone nor the insulin-treated group differed significantly from control subjects with respect to lipid and lipoprotein concentrations. Diabetics treated with diet plus sulphonylurea, however, differed significantly from the control group with regard to the following parameters (median and range); plasma triglycerides (210 [75-620) mg/dl; p less than 0.01)] and intermediate density lipoproteins (65 (10-338) mg/dl; p less than 0.05)) were higher; low density lipoproteins (236 (82-418) mg/dl; p less than 0.05)) and high density lipoproteins2 (HDL2) [51 (12-121) mg/dl; p less than 0.01)] concentrations were lower. When data from all 85 studied individuals were analysed together, significant positive correlations were observed between fasting blood glucose and plasma triglyceride concentration (r = 0.28, p less than 0.01), and between fasting blood glucose and plasma very low density lipoproteins (VLDL) (r = 0.23, p less than 0.05). A negative correlation was found between blood glucose and plasma HDL2 (r = -0.29, p less than 0.01). In addition, VLDL correlated negatively with HDL2 (r = -0.89, p less than 0.001) but not with plasma HDL3 concentration. It is concluded that the deranged lipoprotein metabolism in diabetes mellitus may be better controlled by insulin than by sulphonylureas.
D000328:Adult; D000368:Aged; D001786:Blood Glucose / Q000032:analysis; D001835:Body Weight; D003920:Diabetes Mellitus / Q000097:blood / Q000188:drug therapy*; D003927:Diet, Diabetic; D005260:Female; D005905:Glyburide / Q000627:therapeutic use*; D006801:Humans; D007328:Insulin / Q000097:blood / Q000627:therapeutic use*; D008074:Lipoproteins / Q000097:blood*; D008297:Male; D008875:Middle Aged; D014044:Tolbutamide / Q000627:therapeutic use*
D001786:Blood Glucose; D007328:Insulin; D008074:Lipoproteins; D014044:Tolbutamide; D005905:Glyburide